Homocarnosine or acylhomocarnosine salts
    5.
    发明公开
    Homocarnosine or acylhomocarnosine salts 失效
    同种异黄酮酸酰基卡诺昔康盐

    公开(公告)号:EP0192317A1

    公开(公告)日:1986-08-27

    申请号:EP86300076.6

    申请日:1986-01-07

    发明人: Takaya, Masahiro

    IPC分类号: C07D233/64 A61K31/415

    CPC分类号: C07D233/64

    摘要: Homocarnosine or acylhomocarnosine aluminum and zinc salts of the formula:
    wherein R represents a hydrogen atom or an acyl group; M represents a zinc atom or an aluminum atom; a denotes 1, 2 or 3; and b denotes 0,1 or 2, provided that when a denotes 1, b denotes 0 and M represents zinc, a hydrogen atom is omitted from the homocarnosine or acylhomocarnosine residue, have antiulcer and wound healing-promoting activities and very low toxicity.

    摘要翻译: 同型半胱氨酸或酰基焦马来诺铝和下式的锌盐:其中R表示氢原子或酰基; M表示锌原子或铝原子; a表示1,2或3; 并且b表示0,1或2,条件是当a表示1时,b表示0且M表示锌,从高卡诺胶或酰基卡马诺糖残基中省略氢原子,具有抗溃疡和伤口愈合促进活性,毒性非常低。

    Porphyrin derivatives
    9.
    发明公开
    Porphyrin derivatives 失效
    Porphyrinderivate。

    公开(公告)号:EP0335539A2

    公开(公告)日:1989-10-04

    申请号:EP89302670.8

    申请日:1989-03-17

    IPC分类号: C07D487/22 A61K31/40

    CPC分类号: C07D487/22

    摘要: Porphyrin derivatives of the formula A:
    wherein each R₁ independently is a hydrogen atom, a C₁-C₄ alkyl group, an ethenyl group, or a 2-hydroxy­ethyl group; one R₂ is a hydroxyl group and the other R₂ is
    (each A, B, and C is independently a C₁-C₄ alkyl group; X⁻ is an halogen or organic acid ion; and m is an integer of 1 to 23, and pharmaceutically acceptable salts are photosensitive, less accumulable in the skin and specifically accumulative in cancer tissues as compared with known porphyrins. They can be obtained from the corresponding diester compounds.

    摘要翻译: 式A的卟啉衍生物:其中每个R 1独立地是氢原子,C 1 -C 4烷基,乙烯基或2-羟基乙基; 一个R2是羟基,另一个R2是(每个A,B和C独立地是C1-C4烷基; X是卤素或有机酸离子; m是整数1 和其药学上可接受的盐是光敏的,在已知的卟啉中与皮肤相比较少积累,特别是在癌组织中累积,它们可以从相应的二酯化合物中获得。

    Pheophorbide derivatives
    10.
    发明公开
    Pheophorbide derivatives 失效
    脱镁叶绿酸衍生物

    公开(公告)号:EP0322198A2

    公开(公告)日:1989-06-28

    申请号:EP88312075.0

    申请日:1988-12-20

    CPC分类号: C07D487/22 A61K41/0071

    摘要: Novel pheophoribide derivative of the general formula:
    (wherein Z is O or NH; n is an integer of 1 to 6; Y is NR′R˝ or
    (wherein R′, R˝ and R‴ are the same or different and each represents a C₁ to C₄ lower alkyl group; and X⁻ is a halogen or organic acid ion); R₁ is an ethenyl group, C₁ to C₄ lower alkyl group or
    (wherein m is an integer of 0 to 6, R₆ is H or a C₁ to C₄ lower alkyl group); R₂ is CH₃, CHO or CH₂OH; either of R₃ and R₄ is H, with the other being OH, or both of them combine to represent =O; R₅ is H or CO₂CH₃) are useful in photodynamic diagnosis and therapy of cancer tissues.

    摘要翻译: 具有以下通式的新型酚硫代磷酸酯衍生物:(其中Z是O或NH; n是1至6的整数; Y是NR'R 6或(其中R',R 7和R 8相同或不同,并且各自表示 C 1 -C 4低级烷基; X - 是卤素或有机酸根离子); R 1是乙烯基,C 1 -C 4低级烷基或(其中m是0-6的整数,R 6是H或C 1 至C 4低级烷基); R 2是CH 3,CHO或CH 2 OH; R 3和R 4中任何一个是H,另一个是OH,或二者合在一起代表= O; R 5是H或CO 2 CH 3) 和癌症组织的治疗。